Publications: 1998-2000

To view the publications, please select the year of publication first followed by clicking on the (+) sign to access the full list of publications for that year. When you are ready to view the publications for another year, please click on the (-) sign to return to the initial default display. 

Publications: 2000

Nabholtz J, Buzdar A, Pollak M, Harwin W, Burton G, Mangalik A, Steinberg M, Webster A, Von Euler M. Anastrazole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women. J Clin Oncol 18: 3758-67, 2000.

download

Pollak MThe question of a link between insulin-like growth factor physiology and neoplasia. Growth Hormone IGF Res 10 Suppl B: 21-4, 2000.

download

Zi X, Zhang J, Agarwal R, Pollak M. Silibinin up-regulates insulin-like growth binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells. Cancer Res 60: 5617-20, 2000.

download

Byrne C, Colditz G, Willett W, Speizer F, Pollak M, Hankinson S. Plasma Insulin-like Growth Factor (IGF) I, IGF-binding Protein 3, and mammographic Density. Cancer Res 60: 3744-8, 2000.

download

Wilkin F, Paquette J, Ledru E, Mamelin C, Pollak M, Deal C. H19 sense and antisense transgenes modify insulin-like growth factor-II mRNA levels. Eur J Biochem 267: 4020-7, 2000.

download

Platz EA, Pollak MN, Willett W, Giovannucci E. Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3. J Am Acad Dermatol 42: 1003-7, 2000.

download

Pollak M. Insulin-like growth factor physiology and cancer risk. Eur J Cancer 36: 1224-8, 2000. 

download

Giovannucci E, Pollak M, Platz E, Willett W, Stampfer M, Majeed N, Colditz G, Speizer F, Hankinson S. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9: 345-9, 2000.

download

Foulkes WD, Chappuis PO, Wong N, Brunet J, Vesprini D, Rozen F, Yuan ZQ, Pollak MN, Kuperstein G, Narod SA, Bégin LR. Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome. Ann Oncol 3: 307-13, 2000.

download

Miyake H, Pollak M, Gleave M. Castration-induced upregulation of IGFBP-5 potentiates IGF-I activity and accelerates progression to androgen-independence in prostate cancer models. Cancer Res 60: 3058-64, 2000.

download

Huynh H, Beamer W, Pollak M, Chan T. Modulation of transforming growth factor beta 1 gene expression in the mammary gland by insulin-like growth factor I and octreotide. Int J Oncol 16: 277-81, 2000.

download

Publications: 1999

Platz E, Pollak M, Rimm E, Majeed N, Tao Y, Willett W, Giovannucci E. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiol Biomarkers Prev 8: 1107-10, 1999.

download

Nickerson T, Pollak M. Bicalutamide (Casodex)-induced prostate regression involves increased gene expression of insulin-like growth factor binding proteins. Urology 54: 1120-5, 1999.

download

Buhlmann C, Borchers T, Pollak M, and Spener F. Fatty acid metabolism in human breast cancer cells (MCF7) transfected with heart-type fatty acid binding protein. Mol Cell Biochem 199: 41-8, 1999.

download

Rozen F, Pollak M. Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins. Int J Oncol. 15: 589-94, 1999.

download

Nickerson T, Miyake H, Gleave M, and Pollak M Castration-induced apoptosis of androgen-dependent Shinogi carcinoma is associated with increased expression of genes encoding IGF-binding proteins. Cancer Res 59: 3392-5, 1999.

download

Nickerson T, Zhang J, Pollak M. Regression of DMBA-induced breast carcinoma following ovariectomy is associated with increased expression of genes encoding insulin-like growth factor binding proteins. Int J Oncol 14: 987-90, 1999.

download

Rosen C and Pollak M. Circulating IGF-I: a new perspective for a new century. Trends Endocrinol Metab 10: 136-41, 1999.

download

Pollak M. IGF-I physiology and breast cancer. Recent Results Cancer Rev 17: 383-90, 1998-1999.

download

Pollak M, Beamer W, Zhang J. Insulin-like growth factors and prostate cancer. Cancer Metastasis Rev 17: 383-90, 1999.

download

Ma J, Pollak M, Giovannucci E, Chan J, Tao Y, Hennekens C, Stampfer M. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein 3. J Natl Cancer Inst 91: 620-5, 1999

[see also favorable editorial comment [.pdf] - J Natl Cancer Inst 91: 579-581, 1999]

download

Ingle J, Suman V, Kardinal C, Krook J, Mailliard J, Veeder M, Loprinzi C, Dalton R, Hartmann L, Conover C, Pollak M. A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma. Cancer 85: 1284-92, 1999.

download

Publications: 1998

Burrow S, Andrulis I, Pollak M, Bell R. Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcoma. J Surg Oncol 69: 21-7, 1998.

download

Rozen F, Zhang J, Pollak M. Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. Int J Oncol 13: 865-9, 1998.

download

Huynh H, Pollak M, Zhang J. Regulation of IGF-II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB 1089. Int J Oncol 13: 137-143, 1998.

download

Pollak M. Effects of anti-estrogens on insulin-like growth factor-I physiology systemically and in the uterus. Eur J Cancer 34 (Supp 4) S1-S8, 1998.

download

Hankinson S, Willett W, Colditz G, Hunter D, Michaud D, Deroo B, Rosner B, Speizer F, Pollak M. Circulating concentrations of insulin-like growth factor I and risk of breast cancer. Lancet 351: 1393-96, 1998.

[see also favorable editorial comment [.pdf] : Lancet 351: 1373-4, 1998]

download

Pollak M. Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Res Treat 47: 209-17, 1998.

download

Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens C, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563-566, 1998

[see also favorable editorial comment [.pdf] - Science 279: 475, 1998]

download

Pollak M, Schally A. Mechanisms of antineoplastic action of somatostatin analogs. Proc Soc for Exp Biol Med 217: 143-52, 1998.

download

Nickerson T, Pollak M,Huynh H. Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding IGF binding proteins 2,3,4, and 5. Endocrinology 139: 807-810, 1998.

download